PPARGC1A and small cell lung carcinoma: To determine whether these subtype-specific expression patterns are observable in a broader clinical context, our datasets from PARCB tumors with PGC-1α overexpression were projected onto datasets from SCLC samples in the CCLE and from the clinical study by George et al. 2015 (Fig. 6H).